We describe a case of eruptive pseudoangiomatosis triggered by the oral contraceptive Minulet® containing gestodene and ethinyloestradiol. A possible immunological mechanism in the induction of the skin lesions is suggested by the histopathological findings and a positive macrophage migration inhibition factor (MIF) test for the progesterone components in Minulet®.
|Number of pages||3|
|Journal||Journal of the European Academy of Dermatology and Venereology|
|State||Published - 1997|
- Eruptive pseudoangiomatosis
- Oral contraceptive